3
Announcements
Trials
Browse
Landscape
Status
Completed
181
Recruiting
128
Terminated
110
Active not recruiting
66
Unknown
29
Withdrawn
19
Not yet recruiting
11
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER
4
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
12
Hematologic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Breast Neoplasms
5
Urinary Bladder Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Myasthenia Gravis
3
Multiple Myeloma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Heart Failure
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Diabetes Mellitus, Type 2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
INDUSTRY
×
Squamous Cell Carcinoma of Head and Neck
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled